Navigation Links
Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
Date:4/9/2008

FRANKLIN, Mass., April 9, 2008 /PRNewswire-FirstCall/ - Echo Therapeutics (OTC Bulletin Board: ECTE) today announced positive results from its human feasibility study of the Prelude(TM) SkinPrep System, Echo's next-generation, needle-free, non-invasive skin permeation medium for its Symphony(TM) tCGM System, a novel transdermal continuous glucose monitoring (tCGM) system in development for diabetes home use and hospital critical care markets. Prelude incorporates Echo's patented skin permeation control feedback technology into a comfortable, wireless, hand-held device used to prepare a small area of the skin for the non-invasive, biosensor and monitoring components of its Symphony tCGM system. Results of the feasibility study on healthy subjects demonstrate that Prelude safely and effectively permeated the skin so that the Symphony tCGM System could continuously monitor blood glucose levels reliably over a 24-hour period. Echo plans to use Prelude in the remaining pilot and pivotal clinical studies necessary to commercialize the Symphony tCGM System, including clinical studies scheduled to begin in the second quarter of this year.

"Painless, needle-free, non-invasive skin permeation is critical to our development and commercial goals for Symphony. Building on the positive results from our recently completed Symphony tCGM System study at Tufts Medical Center, we are pleased to have achieved technical feasibility of Prelude in humans well ahead of schedule," said Patrick Mooney, M.D., Echo's Chairman and CEO. "With Prelude, we now have a needle-free, safe, effective, easy-to-use and low-cost skin permeation system for Symphony. We look forward to the results of our near term clinical trials in the diabetes home use and hospital critical care settings."

"These data demonstrate that Prelude, which incorporates our patented feedback control mechanism, can achieve precise, individually optimized skin permeation to enable Symphony to provide users with
'/>"/>

SOURCE Echo Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Fla. , Jan. 23, 2015  Today the U.S. ... Novartis, Bexsero® for the prevention of serogroup B ... Bexsero and Pfizer,s vaccine Trumenba®, which received FDA approval ... prevent this devastating disease. "I have ...
(Date:1/23/2015)... analysis of Centers for Medicare and Medicaid Services, (CMS) ... percent of seniors chose lower-cost preferred pharmacy plans that ... The findings were released by Drug Channels . ... of Medicare Part D," said Pharmaceutical Care Management Association ...
(Date:1/23/2015)... 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is investigating ... Inc. ("Advaxis" or the "Company") (NASDAQ: ADXS ... duties to shareholders. On January 21, 2015, ... that Advaxis had misrepresented the clinical data for its ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2
... Highlights GeneXpert(R) System ... ... (Nasdaq:,CPHD) today announced the U.S. Food & Drug Administration (FDA) ... the Clinical Laboratory Improvement Amendments (CLIA).,The new test is designed ...
... from the Landmark ATHENA ... Study, PARIS, Nov. 4 , ... 14.00-15.00am CET, Background:, -- AF is a growing health concern directly responsible for ... a global prospective database like RecordAF, which takes a closer look ...
Cached Medicine Technology:Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized 'Moderate Complexity' by FDA 2Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized 'Moderate Complexity' by FDA 3Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized 'Moderate Complexity' by FDA 4Tackling Atrial Fibrillation and Associated Cardiovascular Risk 2
(Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo and ... federal multidistrict litigation underway in U.S. District Court, District ... Order dated January 20th, the Court has remanded a ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Joan Lunden, ... keynote speaker at the upcoming 32nd Annual Miami ... Physicians’ Education Resource®, LLC (PER®) , shares that ... have gone undetected if she had not followed up ...
(Date:1/22/2015)... 22, 2015 IsoComforter, Inc. has introduced the ... patented IsoTube design to treat specific body parts and muscle ... progressive and easy to use patented cold therapy machine with ... related orthopedic and muscle injuries. IsoComforter has become the ...
(Date:1/22/2015)... As interest in the value of spiritual support as ... Rev. Eric J. Hall , president and CEO of the ... the keynote speaker on January 27 at an international summit ... The conference, “Hope and Resilience: Innovative and Interdisciplinary Spiritual Care,” ...
(Date:1/22/2015)... Step into a macabre world where ... of Virginia. Wicked Plants, the Museum’s latest featured exhibition, ... poisonous, carnivorous and diabolical plants inside of a dilapidated, ... the biochemical, physical and neurological processes between botanicals and ...
Breaking Medicine News(10 mins):Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... SIR,s 37th Annual Scientific Meeting: Nearly 5,300 physicians, ... sessions: "Extreme IR" showcases the exciting ways that ... will report on new research related to multiple ... "I/O Evidence: From Science to Practice." There will ...
... 9 (HealthDay News) -- Zebras evolved from all black ... them from feeding, a new study contends. ... and white stripes are the least-attractive hide pattern to ... The researchers found that horseflies are drawn to ...
... 9, 2012) In a study to be presented ... The Pregnancy Meeting , in Dallas, Texas, researchers will ... delivery via cesarean section appear to know little about ... second cesarean or trial of labor to attempt a ...
... on several projects, including the mapping of the genomes ... from 577 billion base pairs of sequence data. The ... as one of the scientific breakthroughs of 2011. Large-scale ... sciences, healthcare and agricultural research. Henry Yang, Executive ...
... 8 (HealthDay News) -- Middle-school kids who participate in lots ... kids, new research finds. Yet, students with teammates who ... of peers is more pronounced among girls. "This result ... of others even though there might be a protective effect ...
... Virginia Commonwealth University Medical Center,s VCU Massey Cancer ... VA) and Old Dominion University (Norfolk, VA) have ... (WT1) results in downregulation of CD97 gene expression ... characteristic invasiveness exhibited by glial tumor cells. This ...
Cached Medicine News:Health News:Media alert: Society of Interventional Radiology's 37th Annual Scientific Meeting 2Health News:Bug Bites May Have Caused Zebras' Stripes 2Health News:Study finds pregnant women with prior cesarean choose the delivery method preferred by their doctor 2Health News:VIB and BGI organize joint genomics meeting, Feb. 15, 2012, Belgium 2Health News:VIB and BGI organize joint genomics meeting, Feb. 15, 2012, Belgium 3Health News:CD97 gene expression and function correlate with WT1 protein expression and glioma invasiveness 2Health News:CD97 gene expression and function correlate with WT1 protein expression and glioma invasiveness 3
The combination of new measuring principle - Pupil Zone Imaging Method - and unique technology - SLD - offers high accuracy and reliability in refraction measurement....
... Module ACM-8 loads and unloads two centrifuges ... Identification via Cap Recognition the tube type ... in batches of three 5 position racks ... the single centrifuge ACM can be offered ...
... The Recapping System RCS 800 closes various ... efficient and easy way. Different tube heights and ... sealed tubes can be used for send-outs. The ... RSD 800, Aliquoting System RSD 800 and High ...
... detect sequences of the following viruses: ... and 3; influenza virus A and ... and B. Laboratories may use ... *Analyte Specific Reagents. Analytical ...
Medicine Products: